SS Innovations International (SSII) Cash & Equivalents (2016 - 2026)
SS Innovations International's (SSII) quarterly Cash & Equivalents came in at $16.0 million in Q1 2026, up 0.67% year-on-year from $15.9 million in Q1 2025, and up 398.37% quarter-over-quarter from $3.2 million in Q4 2025.
SS Innovations International (SSII) Cash & Equivalents (2016 - 2026) Analysis & Trends
SS Innovations International has disclosed Cash & Equivalents across 11 years of filings, most recently posting $16.0 million for Q1 2026.
- Cash & Equivalents for Q1 2026 came in at $16.0 million, up 0.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $16.0 million (up 0.67% YoY), and the FY2025 annual result was $3.2 million, up 587.33% from the prior year.
- Cash & Equivalents came in at $16.0 million for Q1 2026 at SS Innovations International, up from $3.2 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $16.0 million in Q1 2026 to a low of $217177.0 in Q4 2022.
- The 5-year median for Cash & Equivalents is $608215.0 (2024), against an average of $3.8 million.
- Across the five-year window, Cash & Equivalents plunged 96.66% in 2024 and surged 2478.39% in 2025, its largest moves.
- SS Innovations International's Cash & Equivalents stood at $217177.0 in 2022, then surged by 831.16% to $2.0 million in 2023, then sank by 76.93% to $466500.0 in 2024, then surged by 587.33% to $3.2 million in 2025, then soared by 398.37% to $16.0 million in 2026.
- The last three Cash & Equivalents figures came in at $16.0 million (Q1 2026), $3.2 million (Q4 2025), and $5.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 6.80 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 2.45 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.03 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 1.12 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 439.60 Mn |
| 10 | SS Innovations International | 689.95 Mn | 666.34 Mn | 5.33 Mn | 15.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.98 Mn |
| Dec 31, 2025 | 3.21 Mn |
| Sep 30, 2025 | 5.68 Mn |
| Jun 30, 2025 | 11.38 Mn |
| Mar 31, 2025 | 15.87 Mn |
| Dec 31, 2024 | 466,500.00 |
| Sep 30, 2024 | 220,357.00 |
| Jun 30, 2024 | 608,215.00 |
| Mar 31, 2024 | 948,119.00 |
| Dec 31, 2023 | 2.02 Mn |
| Sep 30, 2023 | 6.60 Mn |
| Jun 30, 2023 | 423,062.00 |
| Mar 31, 2023 | 448,543.00 |
| Dec 31, 2022 | 217,177.00 |
| Sep 30, 2022 | 514,143.00 |
| Jun 30, 2022 | 261,089.00 |
| Mar 31, 2022 | 346,869.00 |
| Dec 31, 2021 | 405,774.00 |
| Sep 30, 2021 | 205,195.00 |
| Jun 30, 2021 | 307,565.00 |